[Severe esophageal stenosis secondary to the administration of chemotherapy in a patient with acute myeloblastic leukemia].
Canales Albendea
M A
MA
Alvarez Román
M T
MT
Villanueva Pavón
R
R
Hernández Navarro
F
F
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002066:Busulfan / Q000009:adverse effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004106:Dilatation; D004940:Esophageal Stenosis / Q000209:etiology*; D004941:Esophagitis / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D019172:Transplantation Conditioning / Q000009:adverse effects; D014456:Ulcer / Q000139:chemically induced* / Q000150:complications / Q000628:therapy
D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D002066:Busulfan